<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Sickle Cell Disease Association of America Inc.</provider_name><provider_url>https://www.sicklecelldisease.org</provider_url><author_name>admin</author_name><author_url>https://www.sicklecelldisease.org/author/admin/</author_url><title>GBT and SCDAA to Host 8th Annual Sickle Cell Disease (SCD) Therapeutics Conference - Sickle Cell Disease Association of America Inc.</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="gFp04J9UnJ"&gt;&lt;a href="https://www.sicklecelldisease.org/2019/09/05/gbt-and-scdaa-to-host-8th-annual-sickle-cell-disease-scd-therapeutics-conference/"&gt;GBT and SCDAA to Host 8th Annual Sickle Cell Disease (SCD) Therapeutics Conference&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.sicklecelldisease.org/2019/09/05/gbt-and-scdaa-to-host-8th-annual-sickle-cell-disease-scd-therapeutics-conference/embed/#?secret=gFp04J9UnJ" width="600" height="338" title="&#x201C;GBT and SCDAA to Host 8th Annual Sickle Cell Disease (SCD) Therapeutics Conference&#x201D; &#x2014; Sickle Cell Disease Association of America Inc." data-secret="gFp04J9UnJ" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><description>GlobalBlood Therapeutics, Inc. (GBT) (NASDAQ: GBT) and the Sickle Cell Disease Association of America, Inc. (SCDAA) announced that they will host the 8th Annual Sickle Cell Disease (SCD) Therapeutics Conference on Tuesday, September 10, 2019, at The Westin Washington, D.C. U.S. Representative Robin Kelly, chair of the Congressional Black Caucus Health Braintrust, will deliver the [&hellip;]</description></oembed>
